Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-031542

CEO and Chairman sold 150,000 shares at an average $40.23 ($6,034,424)

  • CEO and Chairman acquired 150,000 shares (option exercise)
  • CEO and Chairman gave 100,000 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

ROBINS CHAD M · CEO and Chairman

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2020-05-19 Exercise or conversion : show line 1 in the form +50,000 $0.33 $16,500 1,928,180 D
2020-05-19 Sale : show line 2 in the form −900 $39.31 $35,379 1,927,280 D
2020-05-19 Sale : show line 3 in the form −49,100 $39.95 $1,961,545 1,878,180 D
2020-05-20 Exercise or conversion : show line 4 in the form +50,000 $0.33 $16,500 1,928,180 D
2020-05-20 Sale : show line 5 in the form −50,000 $40.46 $2,023,000 1,878,180 D
2020-05-21 Exercise or conversion : show line 6 in the form +50,000 $0.33 $16,500 1,928,180 D
2020-05-21 Sale : show line 7 in the form −50,000 $40.29 $2,014,500 1,878,180 D
2020-05-21 Gift : show line 8 in the form −100,000 1,778,180 D
Open-market sales · 150,000 sh · avg $40.23 · $6,034,424

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2020-05-19 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −50,000 551,560 D
2020-05-20 Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) −50,000 501,560 D
2020-05-21 Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) −50,000 451,560 D
Loading xslF345X03/doc4.xml…